Logo image of BFRI

BIOFRONTERA INC (BFRI) Stock Analyst Earnings Estimates

NASDAQ:BFRI - Nasdaq - US09077D2099 - Common Stock - Currency: USD

0.93  -0.04 (-3.73%)

After market: 0.9418 +0.01 (+1.27%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
BFRI revenue by date.BFRI revenue by date.
28.67M
18.96%
34.071M
18.84%
37.321M
9.54%
41.708M
11.75%
48.835M
17.09%
67.883M
39.00%
89.363M
31.64%
117.64M
31.64%
142.48M
21.12%
165.06M
15.85%
EBITDA
YoY % growth
BFRI ebitda by date.BFRI ebitda by date.
-17.19M
-35.78%
-20.311M
-18.16%
-16.061M
20.92%
-7.038M
56.18%
-2.856M
59.42%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
BFRI ebit by date.BFRI ebit by date.
-17.71M
-34.17%
-21.375M
-20.69%
-17.21M
19.49%
-9.736M
43.43%
-1.989M
79.57%
14.088M
808.30%
18.135M
28.73%
36.675M
102.23%
49.921M
36.12%
63.946M
28.09%
Operating Margin
BFRI operating margin by date.BFRI operating margin by date.
-61.77%-62.74%-46.11%-23.34%-4.07%20.75%20.29%31.18%35.04%38.74%
EPS
YoY % growth
BFRI eps by date.BFRI eps by date.
-9.60
83.16%
-19.27
-100.73%
-4.16
78.41%
-1.01
75.60%
-0.21
79.40%
0.41
295.12%
N/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth
-0.43
-756.80%
-0.31
68.26%
0.18
173.44%
-0.17
63.11%
Revenue
Q2Q % growth
8.466M
8.00%
9.741M
8.09%
14.735M
17.33%
10.71M
24.71%
EBITDA
Q2Q % growth
-3.06M
36.42%
-2.652M
34.23%
612K
208.70%
-102K
97.64%
EBIT
Q2Q % growth
-3.857M
23.95%
-2.94M
40.72%
1.725M
200.76%
-1.632M
64.11%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-0.47
83.68%
-0.22-0.25-114.32%
Q4 2024
Q2Q % growth
-0.25
86.11%
-0.03-0.22-880.39%
Q3 2024
Q2Q % growth
-0.98
78.88%
-0.85-0.13-15.06%
Q2 2024
Q2Q % growth
-0.05
99.31%
-0.790.7493.63%
Q1 2024
Q2Q % growth
-2.88
48.57%
-1.19-1.69-141.33%
Q4 2023
Q2Q % growth
-1.80
35.71%
-1.21-0.59-48.29%
Q3 2023
Q2Q % growth
-4.64
-110.91%
-3.86-0.78-20.19%
Q2 2023
Q2Q % growth
-7.23
-623.00%
-4.70-2.53-53.76%
Q1 2023
Q2Q % growth
-5.60
-55.56%
-3.98-1.62-40.77%
Q4 2022
Q2Q % growth
-2.80
-1,766.67%
-2.24-0.56-24.78%
Q3 2022
Q2Q % growth
-2.20
-10.00%
-5.923.7262.81%
Q2 2022
Q2Q % growth
-1.00 -6.945.9485.58%
Q1 2022
Q2Q % growth
-3.60 -3.26-0.34-10.29%
Q4 2021
Q2Q % growth
-0.15 -0.180.0318.30%
Q3 2021
Q2Q % growth
-2.00 -0.59-1.41-238.07%
BFRI Yearly EPS VS EstimatesBFRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -10 -20 -30 -40 -50
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
8.588M
8.54%
10.761M-2.173M-20.19%
Q4 2024
Q2Q % growth
12.559M
18.53%
14.821M-2.262M-15.26%
Q3 2024
Q2Q % growth
9.012M
1.30%
10.207M-1.195M-11.71%
Q2 2024
Q2Q % growth
7.839M
34.05%
8.371M-532K-6.36%
Q1 2024
Q2Q % growth
7.912M
-9.40%
11.074M-3.162M-28.55%
Q4 2023
Q2Q % growth
10.596M
4.50%
11.752M-1.156M-9.84%
Q3 2023
Q2Q % growth
8.896M
105.93%
8.603M293K3.41%
Q2 2023
Q2Q % growth
5.848M
31.12%
6.304M-456K-7.23%
Q1 2023
Q2Q % growth
8.733M
-10.43%
9.333M-600K-6.43%
Q4 2022
Q2Q % growth
10.14M
10.58%
10.565M-425K-4.02%
Q3 2022
Q2Q % growth
4.32M
-0.23%
4.394M-74K-1.68%
Q2 2022
Q2Q % growth
4.46M
-23.89%
4.629M-169K-3.65%
Q1 2022
Q2Q % growth
9.75M
105.70%
10.098M-348K-3.45%
Q4 2021
Q2Q % growth
9.17M
7.00%
9.422M-252K-2.67%
Q3 2021
Q2Q % growth
4.33M
33.23%
4.399M-69K-1.57%
Q2 2021
Q2Q % growth
5.86M
144.17%
%
Q1 2021
Q2Q % growth
4.74M
2.60%
%
BFRI Yearly Revenue VS EstimatesBFRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -27.27% 0% -30.07%
Revenue0% -8.79% 0% -5.75%